Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Biostem Technologies New (BSEM)

Biostem Technologies New (BSEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026 GlobeNewswire - Wed Apr 8, 6:00AM CDT

POMPANO BEACH, Fla., April 08, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing and commercialization of...

BSEM : 5.1050 (-1.83%)
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference GlobeNewswire - Tue Mar 31, 3:05PM CDT

POMPANO BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization...

BSEM : 5.1050 (-1.83%)
BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025 GlobeNewswire - Mon Mar 30, 6:00AM CDT

POMPANO BEACH, Fla., March 30, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization...

BSEM : 5.1050 (-1.83%)
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire - Tue Mar 24, 3:05PM CDT

POMPANO BEACH, Fla., March 24, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization...

BSEM : 5.1050 (-1.83%)
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair GlobeNewswire - Mon Mar 23, 10:40AM CDT

Pompano Beach, FL, March 23, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for...

BSEM : 5.1050 (-1.83%)
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair GlobeNewswire - Mon Mar 23, 6:00AM CDT

POMPANO BEACH, Fla., March 23, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived...

BSEM : 5.1050 (-1.83%)
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026 GlobeNewswire - Wed Mar 11, 3:05PM CDT

POMPANO BEACH, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal...

BSEM : 5.1050 (-1.83%)
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference GlobeNewswire - Fri Feb 20, 6:00AM CST

POMPANO BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal...

BSEM : 5.1050 (-1.83%)
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research GlobeNewswire - Tue Feb 3, 3:05PM CST

POMPANO BEACH, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal...

BSEM : 5.1050 (-1.83%)
BioTissue Holdings, Inc Strengthens Strategic Focus on Ocular Innovation with Sale of Surgical and Wound Care Business to BioStem Technologies PR Newswire - Wed Jan 21, 5:00PM CST

BioTissue Deepens Commitment to Ocular Market Leadership

BSEM : 5.1050 (-1.83%)

Barchart Exclusives

Should You Chase the Relief Rally in Delta Air Lines Stock? Barchart - 8 minutes ago
Delta Air Lines just jumped more than 11% on an Iran ceasefire–driven oil pullback. Does this prompt investors to 'Buy' here? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.